Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Disc Medicine Inc (IRON)

Disc Medicine Inc (IRON)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Disc Medicine to Participate in Upcoming Investor Conferences

IRON : 63.51 (+1.53%)
Disc Medicine Reports Third Quarter 2024 Financial Results and Provides Business Update

IRON : 63.51 (+1.53%)
Disc Medicine Secures $200 Million in Non-Dilutive Debt Financing from Hercules Capital, Inc.

IRON : 63.51 (+1.53%)
Disc Medicine Announces Multiple Presentations Across Portfolio at the 66th American Society of Hematology (ASH) Annual Meeting

IRON : 63.51 (+1.53%)
Disc Medicine Announces Successful End of Phase 2 Meeting with FDA for Bitopertin in Erythropoietic Protoporphyria (EPP), Including Potential for Accelerated Approval

IRON : 63.51 (+1.53%)
Disc Medicine to Host Conference Call on End of Phase 2 FDA Meeting for Bitopertin in Erythropoietic Protoporphyria (EPP)

IRON : 63.51 (+1.53%)
Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week

IRON : 63.51 (+1.53%)
Disc Medicine Appoints Seasoned Industry Executive Rahul Kaushik, Ph.D. as Chief Technical Officer

IRON : 63.51 (+1.53%)
Disc Medicine Announces Presentation of New Data from Phase 1b Trial of DISC-0974 in Patients with Chronic Kidney Disease (CKD) and Anemia at 2024 American Society of Nephrology (ASN) Kidney Week

IRON : 63.51 (+1.53%)
Stocks Close Mixed as US Manufacturing Strength Dampens Rate Cut Optimism

The S&P 500 Index ($SPX ) (SPY ) Monday closed down -0.20%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.21%. Stock indexes...

$SPX : 5,948.71 (+0.53%)
SPY : 593.67 (+0.54%)
$DOWI : 43,870.35 (+1.06%)
DIA : 438.97 (+1.08%)
$IUXX : 20,740.78 (+0.36%)
QQQ : 504.98 (+0.36%)
ZNZ24 : 109-190 (+0.09%)
WBA : 8.30 (+0.73%)
UHS : 197.61 (+0.05%)
BILL : 89.98 (+2.41%)
FDX : 295.16 (+2.48%)
JBHT : 181.57 (-0.01%)

Barchart Exclusives

1 AI Stock to Buy and Hold for Long-Term Growth
Pure Storage stands out in AI data storage, bolstered by a new partnership with CoreWeave and a solid financial track record, making it an intriguing stock for AI-focused investors Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar